Skip to main content

Table 1 Baseline characteristics of the study population

From: A genetic variant of the atrial natriuretic peptide gene is associated with left ventricular hypertrophy in a non-diabetic population – the Malmö preventive project study

  Total sample Subjects without LVH Subjects with LVH
N 968 820 148
Sex (% women) 30.5 30.6 29.7
Age (years) 67.1 (±5.7) 66.7 (±5.7) 69.4 (±5.2)
Systolic BP (mmHg) 146.0 (±19.3) 145.1 (±19.0) 150.8 (±20.2)
Diastolic BP (mmHg) 84.5 (±10.2) 84.2 (±10.0) 86.6 (±11.3)
Antihypertensive and/or cardioprotective treatment (%) 41.3 37.8 60.8
Hypertension (%) 74.5 71.5 91.1
BMI 27.3 (±3.8) 26.9 (±3.4) 29.8 (±4.8)
FPG (mmol/l)* 5.8 [0.9] 5.8 [1.0] 6.1 [1.0]
  1. Data are expressed as mean (±SD) or median [interquartile range (IQR)]*. BP blood pressure, BMI body mass index, FPG fasting plasma glucose.
\